Organ Preservation Market Research Report 2033

Report Description

Organ Preservation Market Outlook

According to our latest research, the global organ preservation market size reached USD 262.7 million in 2024, demonstrating robust growth driven by increasing organ transplantation procedures worldwide. The market is projected to expand at a CAGR of 6.8% from 2025 to 2033, reaching an estimated value of USD 508.1 million by 2033. Key growth factors include the rising prevalence of chronic diseases, advancements in preservation technologies, and growing awareness about organ donation and transplantation.

One of the primary growth drivers for the organ preservation market is the increasing incidence of end-stage organ failure, which is propelling the demand for organ transplantation procedures globally. The rising burden of lifestyle diseases such as diabetes, hypertension, and obesity has led to a surge in cases of kidney, liver, and heart failure, necessitating organ replacement therapies. Moreover, the aging global population further amplifies the requirement for organ transplants, as older adults are more susceptible to chronic illnesses that can lead to organ dysfunction. As a result, healthcare systems worldwide are focusing on expanding their transplantation infrastructure, thereby boosting the demand for advanced organ preservation solutions.

Technological innovations have played a pivotal role in the expansion of the organ preservation market. The introduction of new preservation techniques, such as hypothermic and normothermic machine perfusion, has significantly improved the viability and function of donor organs during storage and transportation. These advanced methods offer superior outcomes compared to traditional static cold storage solutions by minimizing ischemic injury and extending preservation times. Additionally, the development of specialized preservation solutions, such as the University of Wisconsin Solution and Custodial HTK, has further enhanced the success rates of transplantation procedures. Continuous research and development efforts by key market players are expected to yield even more effective preservation products in the coming years.

Government initiatives and non-profit organizations have also contributed substantially to the growth of the organ preservation market. Many countries have implemented policies to streamline organ donation and transplantation processes, including public awareness campaigns, donor registries, and financial incentives for donors. Collaborative efforts between healthcare providers, transplant centers, and organ banks have led to improved logistics and increased availability of donor organs. Furthermore, growing investments in healthcare infrastructure, especially in emerging economies, are facilitating the adoption of advanced preservation techniques and solutions, thereby supporting market expansion.

From a regional perspective, North America currently dominates the organ preservation market, accounting for the largest revenue share in 2024. This leadership position is attributed to the region's well-established healthcare infrastructure, high prevalence of chronic diseases, and favorable reimbursement policies for transplantation procedures. Europe follows closely, driven by the presence of leading transplant centers and strong government support for organ donation initiatives. Meanwhile, the Asia Pacific region is poised for the fastest growth over the forecast period, fueled by increasing healthcare investments, rising awareness about organ donation, and expanding transplantation programs in countries such as China, India, and Japan.

Get Free Sample Report

Solution Type Analysis

The organ preservation market is segmented by solution type into University of Wisconsin Solution (UW), Custodial HTK, Perfadex, Celsior, and others. Among these, the University of Wisconsin Solution holds the largest market share in 2024, owing to its widespread adoption as the gold standard for preserving abdominal organs, particularly kidneys and livers. The UW solution’s unique composition, which includes potassium lactobionate and hydroxyethyl starch, provides superior protection against cellular edema and ischemic injury during cold storage. Its proven efficacy in maintaining organ viability over extended periods has made it the preferred choice among transplant surgeons and healthcare institutions globally.

Custodial HTK solution, also known as histidine-tryptophan-ketoglutarate solution, is gaining traction in the organ preservation market due to its cost-effectiveness and ease of use. HTK is particularly favored for preserving hearts and pancreases, as it offers excellent myocardial protection and reduces the risk of reperfusion injury. The solution’s low viscosity allows for rapid cooling and efficient organ flushing, which is critical during procurement and transportation. As transplantation procedures become more complex and time-sensitive, the demand for such versatile and user-friendly preservation solutions is expected to rise, further driving market growth.

Perfadex, specifically designed for lung preservation, is another significant segment in the organ preservation market. The solution’s low potassium and dextran-based formulation helps maintain pulmonary vascular integrity and prevent edema formation during cold storage. Perfadex has been instrumental in improving the outcomes of lung transplantation, particularly in cases involving marginal or extended criteria donors. As the number of lung transplants continues to increase globally, the adoption of specialized solutions like Perfadex is anticipated to grow, contributing to the overall expansion of the market.

Celsior and other emerging preservation solutions are also making notable contributions to the market. Celsior, originally developed for heart preservation, is now used for multiple organ types due to its antioxidant properties and ability to minimize ischemia-reperfusion injury. The ongoing research and development of novel preservation solutions, including those tailored for specific organ types or designed for use with machine perfusion technologies, are expected to create new growth opportunities. As the field of organ transplantation evolves, the demand for next-generation preservation solutions that offer improved safety, efficacy, and compatibility with advanced storage techniques will continue to rise.

Report Scope

Organ Type Analysis

By organ type, the organ preservation market is segmented into kidneys, liver, heart, lungs, and others. Kidneys represent the largest segment, accounting for a substantial share of the market in 2024. This dominance is attributed to the high prevalence of end-stage renal disease (ESRD) and the corresponding demand for kidney transplantation, which remains the most frequently performed solid organ transplant worldwide. The growing incidence of diabetes and hypertension, leading causes of ESRD, has further fueled the need for effective kidney preservation solutions. As waiting lists for kidney transplants continue to grow, ensuring optimal preservation of donor kidneys is critical for improving transplantation outcomes and patient survival rates.

The liver segment is also experiencing significant growth, driven by the rising incidence of liver diseases such as cirrhosis, hepatitis, and liver cancer. Liver transplantation is often the only curative option for patients with end-stage liver disease, making the availability of viable donor livers a key determinant of transplantation success. Advances in preservation techniques, including machine perfusion and specialized solutions like the University of Wisconsin Solution, have enhanced the viability of donor livers, enabling longer storage times and expanding the donor pool. The increasing adoption of split-liver and living donor transplantation procedures is further contributing to the demand for advanced liver preservation products.

Heart and lung preservation represent critical segments within the organ preservation market, given the complexity and time sensitivity associated with these transplantation procedures. Heart transplants are often performed in patients with end-stage heart failure, while lung transplants are indicated for conditions such as chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis. The success of these procedures hinges on the ability to preserve organ function and minimize ischemic injury during transport. Specialized solutions such as Custodial HTK for hearts and Perfadex for lungs, combined with advanced machine perfusion technologies, have significantly improved post-transplant outcomes and survival rates.

The "others" category includes organs such as pancreas and intestines, which, although less commonly transplanted, are gaining attention due to advances in surgical techniques and immunosuppressive therapies. The preservation requirements for these organs are unique, necessitating the development of tailored solutions and protocols. As transplantation programs expand and new indications for organ replacement emerge, the demand for specialized preservation products for these less common organs is expected to grow, further diversifying the market landscape.

Preservation Technique Analysis

Preservation technique is a critical segment in the organ preservation market, encompassing static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and other emerging methods. Static cold storage remains the most widely used technique due to its simplicity, cost-effectiveness, and proven track record in maintaining organ viability during short-term storage and transport. This method involves immersing the organ in a preservation solution and storing it at low temperatures to slow metabolic activity and reduce cellular damage. Despite its widespread adoption, static cold storage has limitations in terms of preservation duration and susceptibility to ischemic injury, prompting the exploration of alternative techniques.

Hypothermic machine perfusion (HMP) has emerged as a promising alternative to static cold storage, offering several advantages in terms of organ preservation and transplantation outcomes. HMP involves the continuous circulation of a cold preservation solution through the organ, providing oxygen and nutrients while removing metabolic waste. This dynamic approach helps maintain cellular integrity, reduces the risk of delayed graft function, and extends preservation times, particularly for marginal or extended criteria donor organs. The growing body of clinical evidence supporting the benefits of HMP is driving its adoption in leading transplant centers worldwide, contributing to market growth.

Normothermic machine perfusion (NMP) represents the latest advancement in organ preservation technology, simulating physiological conditions by perfusing the organ with a warm, oxygenated solution. NMP allows for real-time assessment of organ function, repair of ischemic injury, and even therapeutic interventions during storage. This technique has shown promise in improving the viability of high-risk donor organs, increasing the utilization rate, and reducing post-transplant complications. Although NMP is currently more expensive and technically demanding than traditional methods, ongoing research and technological advancements are expected to enhance its accessibility and cost-effectiveness in the near future.

Other emerging preservation techniques, such as subnormothermic perfusion and oxygenated perfusion, are also being explored to further optimize organ preservation and transplantation outcomes. These innovative approaches aim to strike a balance between the metabolic suppression of hypothermia and the functional maintenance of normothermia. As the field of organ preservation continues to evolve, the integration of advanced perfusion technologies with specialized preservation solutions is expected to drive significant improvements in organ quality, expand the donor pool, and ultimately increase the success rates of transplantation procedures.

End User Analysis

The end user segment of the organ preservation market comprises hospitals, transplant centers, organ banks, and others. Hospitals constitute the largest end-user group, as they serve as the primary sites for organ procurement, storage, and transplantation procedures. The presence of specialized transplant units within hospitals enables the seamless coordination of donor organ retrieval, preservation, and implantation. Hospitals also benefit from access to advanced preservation technologies and skilled medical personnel, ensuring optimal outcomes for transplant recipients. As the demand for organ transplants continues to rise, hospitals are increasingly investing in state-of-the-art preservation equipment and solutions to enhance their transplantation capabilities.

Transplant centers play a pivotal role in the organ preservation market, particularly in regions with well-established transplantation programs. These centers are equipped with dedicated teams of surgeons, anesthesiologists, and perfusionists who specialize in the retrieval, preservation, and transplantation of donor organs. Transplant centers often serve as hubs for research and innovation, driving the adoption of advanced preservation techniques such as hypothermic and normothermic machine perfusion. The growing emphasis on multidisciplinary collaboration and continuous quality improvement within transplant centers is expected to further elevate the standards of organ preservation and transplantation care.

Organ banks are critical stakeholders in the organ preservation ecosystem, responsible for the collection, storage, and distribution of donor organs. These facilities adhere to stringent protocols for organ preservation, ensuring that organs remain viable during the interval between procurement and transplantation. Organ banks also play a key role in matching donor organs with suitable recipients, optimizing the allocation process, and minimizing cold ischemia times. The expansion of organ bank networks, particularly in emerging markets, is facilitating greater access to donor organs and supporting the growth of the organ preservation market.

The "others" category includes research institutions, academic medical centers, and non-profit organizations involved in organ preservation and transplantation activities. These entities contribute to the advancement of preservation science through clinical trials, translational research, and the development of novel preservation solutions and techniques. As the field continues to evolve, collaborative efforts among hospitals, transplant centers, organ banks, and research institutions are expected to drive further innovation and improve transplantation outcomes on a global scale.

Opportunities & Threats

The organ preservation market is poised for significant opportunities in the coming years, driven by the increasing prevalence of chronic diseases and the growing demand for organ transplantation worldwide. One of the most promising opportunities lies in the development and commercialization of next-generation preservation solutions and technologies. Innovations in machine perfusion, regenerative medicine, and organ reconditioning have the potential to enhance organ viability, expand the donor pool, and reduce transplantation-related complications. Additionally, the integration of digital health technologies, such as remote monitoring and data analytics, can optimize preservation protocols and improve patient outcomes. As healthcare systems continue to prioritize transplantation as a life-saving intervention, the market is expected to benefit from increased investments in research, infrastructure, and public awareness initiatives.

Another significant opportunity for the organ preservation market is the expansion of transplantation programs in emerging economies. Countries in the Asia Pacific, Latin America, and Middle East & Africa regions are witnessing rapid improvements in healthcare infrastructure, rising disposable incomes, and greater government support for organ donation initiatives. These factors are facilitating the adoption of advanced preservation techniques and solutions, thereby expanding market reach and driving revenue growth. Furthermore, the growing emphasis on international collaboration and knowledge exchange among transplant professionals is accelerating the dissemination of best practices and fostering innovation in organ preservation.

Despite the promising outlook, the organ preservation market faces several restraining factors that could hinder its growth. One of the primary challenges is the high cost associated with advanced preservation technologies, such as hypothermic and normothermic machine perfusion systems. These technologies require substantial capital investment, specialized training, and ongoing maintenance, which may limit their adoption in resource-constrained settings. Additionally, the shortage of donor organs remains a persistent challenge, exacerbated by cultural, religious, and logistical barriers to organ donation. Addressing these challenges will require concerted efforts from governments, healthcare providers, and industry stakeholders to improve organ donation rates, reduce costs, and ensure equitable access to life-saving transplantation procedures.

Regional Outlook

North America continues to lead the global organ preservation market, accounting for a revenue share of USD 94.7 million in 2024. The region’s dominance is underpinned by its advanced healthcare infrastructure, high prevalence of chronic diseases, and robust transplantation programs. The presence of leading transplant centers, favorable reimbursement policies, and strong government support for organ donation initiatives further contribute to North America’s leadership position. The United States, in particular, is a major contributor to market growth, with a well-established network of organ procurement organizations, transplant hospitals, and research institutions driving innovation and adoption of advanced preservation technologies.

Europe holds the second-largest share of the organ preservation market, with a market size of USD 76.9 million in 2024. The region benefits from a high level of public awareness about organ donation, strong regulatory frameworks, and the presence of world-renowned transplant centers. Countries such as the United Kingdom, Germany, France, and Spain have implemented comprehensive organ donation programs and have achieved high transplantation rates. The European market is also characterized by a strong emphasis on research and development, with ongoing clinical trials and collaborative initiatives aimed at improving preservation outcomes and expanding the donor pool. The region is expected to grow at a steady pace, supported by continued investments in healthcare infrastructure and innovation.

The Asia Pacific region is emerging as the fastest-growing market for organ preservation, with a projected CAGR of 8.1% from 2025 to 2033. The market size in this region reached USD 54.2 million in 2024, driven by increasing healthcare expenditures, rising awareness about organ transplantation, and expanding transplantation programs in countries such as China, India, and Japan. Government initiatives to promote organ donation, coupled with improvements in healthcare infrastructure and access to advanced preservation technologies, are fueling market growth. As the region continues to address challenges related to organ donation rates and logistical barriers, the Asia Pacific organ preservation market is expected to witness significant expansion in the coming years.

Get Free Sample Report

Competitor Outlook

The organ preservation market is characterized by intense competition among a diverse group of global and regional players. The competitive landscape is shaped by ongoing research and development efforts, strategic collaborations, and a strong focus on product innovation. Leading companies are investing heavily in the development of advanced preservation solutions, machine perfusion technologies, and integrated systems that offer superior efficacy, safety, and ease of use. The market is also witnessing an increasing number of mergers and acquisitions, as established players seek to expand their product portfolios, enhance their technological capabilities, and strengthen their market presence.

Key market participants are actively engaged in partnerships with hospitals, transplant centers, and research institutions to drive the adoption of their products and solutions. These collaborations often involve clinical trials, educational initiatives, and knowledge-sharing programs aimed at improving transplantation outcomes and advancing the science of organ preservation. Companies are also focusing on expanding their geographic footprint, particularly in high-growth regions such as Asia Pacific and Latin America, by establishing distribution networks, local manufacturing facilities, and training centers. The ability to offer comprehensive solutions that address the unique needs of different organ types, preservation techniques, and end users is a critical differentiator in this competitive market.

In addition to product innovation, regulatory compliance and quality assurance are key priorities for companies operating in the organ preservation market. Adherence to international standards and guidelines, such as those set by the FDA, EMA, and WHO, is essential to ensure the safety and efficacy of preservation solutions and devices. Companies are also investing in post-market surveillance, customer support, and continuous improvement initiatives to maintain high levels of customer satisfaction and loyalty. The competitive landscape is expected to evolve further as new entrants, disruptive technologies, and emerging business models reshape the market dynamics.

Some of the major companies operating in the global organ preservation market include XVIVO Perfusion AB, Dr. Franz Köhler Chemie GmbH, OrganOx Limited, TransMedics Group, Inc., Bridge to Life Ltd., 21st Century Medicine, Inc., Preservation Solutions, Inc., and Paragonix Technologies, Inc. These companies are at the forefront of innovation, offering a wide range of preservation solutions, machine perfusion systems, and related products for various organ types. For example, XVIVO Perfusion AB is a leader in lung and heart preservation technologies, while OrganOx Limited specializes in normothermic machine perfusion systems for liver preservation. TransMedics Group, Inc. is known for its Organ Care System (OCS), which enables normothermic preservation and assessment of donor organs during transport.

Dr. Franz Köhler Chemie GmbH and Bridge to Life Ltd. are prominent players in the development of preservation solutions such as Custodial HTK and University of Wisconsin Solution, respectively. These companies have established strong relationships with transplant centers and hospitals worldwide, ensuring the widespread availability and adoption of their products. 21st Century Medicine, Inc. and Preservation Solutions, Inc. are recognized for their contributions to the development of innovative cryopreservation and perfusion solutions, while Paragonix Technologies, Inc. offers advanced transport and storage devices designed to optimize organ preservation and logistics.

The competitive landscape of the organ preservation market is expected to remain dynamic, with ongoing advancements in preservation science, increasing investments in research and development, and a growing emphasis on collaboration and knowledge exchange. As the demand for organ transplantation continues to rise, companies that can offer comprehensive, cost-effective, and technologically advanced preservation solutions will be well-positioned to capture a larger share of this rapidly evolving market.

Key Players

• TransMedics, Inc.
• XVIVO Perfusion AB
• Paragonix Technologies, Inc.
• OrganOx Limited
• Bridge to Life Ltd.
• Dr. Franz Köhler Chemie GmbH
• Preservation Solutions, Inc.
• Waters Medical Systems LLC
• Institut Georges Lopez (IGL)
• CryoLife, Inc.
• Teva Pharmaceutical Industries Ltd.
• Claris Lifesciences Limited
• Shanghai Genext Medical Technology Co., Ltd.
• Organ Recovery Systems, Inc.
• BioLife Solutions, Inc.
• 21st Century Medicine, Inc.
• Perfusion Solution, Inc.
• Transplant Biomedicals S.L.
• Global Transplant Solutions, Inc.
• S.A.L.F. S.p.A.

Get Free Sample Report